List of programme's course units, number of exams (i.e. how many times the exam was taken in a year) and average marks
The data refer to last year. A course unit may include modules, subgroups, integrated exams. Proficiency tests are not included in the list.
| Course unit | Number of times exam was taken | Average mark |
|---|---|---|
| MOLECULAR MECHANISMS OF DISEASES | 3 | 28 |
| INDUSTRIAL BIOTECHNOLOGICAL APPLICATIONS (I.C.) | 41 | 27 |
| SAFETY AND QUALITY OF BIOPHARMACEUTICAL PRODUCTS (I.C.) | 41 | 28 |
| BIOMOLECULAR SIMULATIONS FOR DRUG DESIGN | 8 | 28 |
| MOLECULAR INTERACTION NETWORKS (I.C.) | 42 | 27 |
| COMPUTATIONAL DRUG DISCOVERY | 31 | 29 |
| BIOSENSORS | 47 | 29 |
| CHEMICAL AND GENOMICS-BASED STRATEGIES IN THE DISCOVERY OF NOVEL DRUG TARGETS | 1 | 30 |
| INDUSTRIAL SCALE UP OF BIOPROCESSES | 1 | 26 |
| NANOFORMULATION OF BIOLOGICALS | 2 | 28 |
| PHARMACOTHERAPY OF BIOLOGICAL DRUGS | 55 | 28 |
| NANOBIOTECHNOLOGY (I.C.) | 37 | 25 |
| NEUROBIOTECHNOLOGY | 49 | 29 |
| EUROPEAN AND INTERNATIONAL REGULATION AND PATENTS | 1 | 26 |
| APPLIED GENOMICS | 3 | 26 |
| LEGAL AND ECONOMIC ASPECTS OF PHARMACEUTICAL BIOTECHNOLOGY (I.C.) | 43 | 28 |
| INDUSTRIAL PROCESSES FOR RECOMBINANT DRUGS | 41 | 26 |
| MICROBIOLOGY AND VACCINES | 46 | 27 |
| GENOMICS OF DISEASES (I.C.) | 51 | 28 |
| ADVANCED IMMUNOLOGY | 23 | 28 |
| ADVANCED TECHNIQUES FOR THE STUDY OF METABOLISM IN VIVO | 37 | 28 |
| ADVANCED BIOPHARMACEUTICAL APPLICATIONS (I.C.) | 3 | 29 |
| ANTIVIRAL AND ANTIMICROBIAL STRATEGIES | 5 | 24 |
| TECHNOLOGICAL INNOVATION AND PRODUCT DEVELOPMENT | 2 | 30 |
| MOLECULAR SIGNALLING TRANSDUCTION | 1 | 23 |
| STEM CELLS AND 3D ORGANOID SYSTEMS | 64 | 30 |
| NANOBIOTECHNOLOGY | 1 | 27 |
